ODI Pharma AB (publ) (NGM:ODI)

ODI Pharma AB Statistics

Total Valuation

ODI Pharma AB has a market cap or net worth of SEK 31.16 million. The enterprise value is 28.28 million.

Market Cap	31.16M
Enterprise Value	28.28M

Important Dates

The last earnings date was Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

ODI Pharma AB has 18.33 million shares outstanding. The number of shares has increased by 25.66% in one year.

Current Share Class	18.33M
Shares Outstanding	18.33M
Shares Change (YoY)	+25.66%
Shares Change (QoQ)	-0.10%
Owned by Insiders (%)	90.83%
Owned by Institutions (%)	n/a
Float	1.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.52
PB Ratio	106.52
P/TBV Ratio	106.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.36
EV / Sales	3.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.04

Current Ratio	1.04
Quick Ratio	1.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.15

Financial Efficiency

Return on equity (ROE) is -1,085.32% and return on invested capital (ROIC) is -576.98%.

Return on Equity (ROE)	-1,085.32%
Return on Assets (ROA)	-35.11%
Return on Invested Capital (ROIC)	-576.98%
Return on Capital Employed (ROCE)	-1,293.24%
Revenue Per Employee	8.86M
Profits Per Employee	-4.45M
Employee Count	1
Asset Turnover	1.32
Inventory Turnover	n/a

Taxes

In the past 12 months, ODI Pharma AB has paid 4,211 in taxes.

Income Tax	4,211
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.46% in the last 52 weeks. The beta is 0.42, so ODI Pharma AB's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-46.46%
50-Day Moving Average	1.39
200-Day Moving Average	2.14
Relative Strength Index (RSI)	59.38
Average Volume (20 Days)	7,741

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ODI Pharma AB had revenue of SEK 8.86 million and -4.45 million in losses. Loss per share was -0.23.

Revenue	8.86M
Gross Profit	2.11M
Operating Income	-3.78M
Pretax Income	-4.44M
Net Income	-4.45M
EBITDA	-3.78M
EBIT	-3.78M
Loss Per Share	-0.23

Balance Sheet

The company has 2.89 million in cash and n/a in debt, giving a net cash position of 2.89 million or 0.16 per share.

Cash & Cash Equivalents	2.89M
Total Debt	n/a
Net Cash	2.89M
Net Cash Per Share	0.16
Equity (Book Value)	292,538
Book Value Per Share	0.02
Working Capital	288,441

Cash Flow

Operating Cash Flow	-5.99M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 23.81%, with operating and profit margins of -42.72% and -50.22%.

Gross Margin	23.81%
Operating Margin	-42.72%
Pretax Margin	-50.17%
Profit Margin	-50.22%
EBITDA Margin	-42.69%
EBIT Margin	-42.72%
FCF Margin	n/a

Dividends & Yields

ODI Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.66%
Shareholder Yield	-25.66%
Earnings Yield	-14.27%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1